January 16, 2019

Readers:

I hate to have to tell you this, but this will be the last issue of the Diabetic Digest. However, there is good news...

This newsletter is NOT ending exactly. It's changing into a "health" based newsletter that will not only cover topics like diabetes, but a wide array of stories, helpful hints, and information that will hopefully benefit you and keep you on the path of healthy living. Actually, that's what we are going to call it, "Healthy Living".

This new and improved publication will mail more frequently than "Diabetic" so keep an eye out for it. The first issue will be mailing soon.

Thank you all so much for reading and corresponding with me about the highs and lows of living with diabetes. (You see what I did there?)

And you can always email me or subscribe to some of the other newsletters I write including the Daily Groaner (Jokes and more) and Celebrity Nooz (All the Hollywood Hubbub), subscribe here: Gophercentral.com

Take care of yourself and get ready for "Healthy Living". Until then...

Regards,
Steve

Comments? Questions? Email Steve

P.S. Did you miss an issue? You can read every issue from the Gophercentral library of newsletters on our exhaustive archives page. Thousands of issues, all of your favorite publications in chronological order. You can read AND comment. Just click GopherArchives

*-- Diabetic News --*

Half of the world's diabetics won't have insulin by 2030, study says
By 2030, about half of the 79 million adults around the globe predicted to have type 2 diabetes won't have access to insulin, a study said.

A modeling study published in The Lancet Diabetes & Endocrinology focused on the price and dwindling supply of the life-saving drug that also helps people with types 1 and 2 diabetes stave off amputation, blindness, kidney failure and stroke.

Researchers from Stanford University projected type 2 diabetes numbers in 221 countries from 2018 and 2030, with half of that group living in China, India and the United States.

During that time, the biggest spike in need could come from Africa, where experts predict the number of people with type 2 diabetes will jump from 700,000 to over 5 million.

Climbing global rates of type 2 diabetes and growing numbers of people living with the disease continue to drive up demand and prices for insulin. The drug can cost as much as $900 per month for people without insurance.

Only three companies currently produce insulin: Novo Nordisk, Sanofi and Lilly. In 2017, diabetes patients sued those companies for driving up insulin prices.

In 2016 an article in the Journal of the American Medical Association reported that the drug's price almost tripled between 2002 and 2013.

"Despite the UN's commitment to treat noncommunicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily difficult for patients to access," Basu said. "Unless governments begin initiatives to make insulin available and affordable, then its use is always going to be far from optimal."

*-- Diabetic Recipe --*

BAKED PECAN CHICKEN
INGREDIENTS:
1/2 package (8-oz. size) chicken fry batter mix
1/3 cup finely chopped pecans
2 teaspoons paprika
1/2 teaspoon salt
1/2 teaspoon poultry seasoning
1/2 cup evaporated milk
6 skinless, boneless chicken breast halves
1/3 cup butter, melted

DIRECTIONS:
Preheat oven to 350 degrees.
Lightly grease a baking sheet; set aside.
In shallow dish, combine fry mix, pecans, paprika, salt and poultry seasoning.
Pour evaporated milk into another shallow dish.
Dip chicken first in milk and then coat with pecan-fry mixture.
Place coated chicken on baking sheet and drizzle with melted butter, turning to coat each chicken breast.
Bake, uncovered for 25 minutes.
Yield: 6 Servings

Categories: Chicken, Main Dishes

Your Winter Hat Deserves An Upgrade. We Got You Covered! Visit Our Site And See What We Added To This Beanie.